Skip to main content
Clinical Trials/CTRI/2020/03/024226
CTRI/2020/03/024226
Completed
Phase 2

A randomized comparative clinical study to evaluate the efficacy of Trayodashanga Guggulu and Sahacharadi Kwatha with and without Greeva Basti in the management of Greevasandhigata Vata w.s.r. to Cervical Spondylosis.

ational Institute of Ayurveda0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: M479- Spondylosis, unspecified
Sponsor
ational Institute of Ayurveda
Enrollment
40
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 10, 2021
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient willing to participate in trial.
  • 2\.The patients in the age group of 18 \- 70 years of either sex.
  • 3\.The patients having clinical sign and symptoms of Greevasandhigata Vata w.s.r. to Cervical Spondylosis.
  • 4\.The patients having chronicity of disease less than 5 years.
  • 5\.The patients having radiological finding of Cervical Spondylosis.

Exclusion Criteria

  • 1\.Recent cervical, spinal, or shoulder surgery or implanted instrumentation or previous surgery for cervical spondylotic myelopathy.
  • 2\.Patients with long term history of steroid and cytotoxic treatment.
  • 3\.Patients having concomitant illness like uncontrollable Hypertension, Diabetes Mellitus etc.
  • 4\.Patients with evidence of malignancy.
  • 5\.Patient participated in any clinical trial within last six months.
  • 6\.Pregnant or lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials